- Nachrichtendetail
-
27.06.2024 14:15:19 - dpa-AFX: *LIGAND PARTNER VERONA PHARMA ANNOUNCES FDA APPROVAL OF OHTUVAYRE FOR MAINTENANCE TREATMENT OF COPD
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 82,700 | 03.07.24 19:00:02 | -2,090 | -2,46% | 83,000 | 87,270 | 84,900 | 84,790 |
